220D-F2 from Rubus ulmifolius kills Streptococcus pneumoniae planktonic cells and pneumococcal biofilms

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Talekar, Sharmila J ^a   Chochua, Sopio ^a   Nelson, Katie ^b   Klugman, Keith P ^a   Quave, Cassandra L ^b,c   Vidal, Jorge E ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

220D F2; ELLAGIC ACID; PLACEBO; PLANT EXTRACT; RUBUS ULMIFOLIUS EXTRACT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PRIMER DNA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BIOFILM; BROTH DILUTION; CELL STRAIN; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; HUMAN; HUMAN CELL; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLATING MEDIUM; POLYMERASE CHAIN REACTION; RUBUS; RUBUS ULMIFOLIUS; STREPTOCOCCUS PNEUMONIAE; BIOREACTOR; CELL LINE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; FLUORESCENCE; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NASOPHARYNX;

ANTI-BACTERIAL AGENTS; BIOFILMS; BIOREACTORS; CELL LINE; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELLAGIC ACID; FLUORESCENCE; HUMANS; MICROBIAL SENSITIVITY TESTS; NASOPHARYNX; PLANT EXTRACTS; RUBUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84901269568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097314     Document Type: Article

References (61)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
2. Jedrzejas MJ (2001) Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev 65: 187-207.
3. Yang F, Xu XG, Yang MJ, Zhang YY, Klugman KP, et al. (2008) Antimicrobial susceptibility and molecular epidemiology of Streptococcus pneumoniae isolated from Shanghai, China. Int J Antimicrob Agents 32: 386-391.
4. van der Poll T, Opal SM (2009) Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374: 1543-1556.
5. Levine OS, Klugman KP (2009) Editorial: Breathing new life into pneumonia epidemiology. Am J Epidemiol 170: 1067-1068.
6. Lynch JP, 3rd, Zhanel GG (2010) Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 16: 217-225.
7. Weycker D, Strutton D, Edelsberg J, Sato R, Jackson LA (2010) Clinical and economic burden of pneumococcal disease in older US adults. Vaccine 28: 4955-4960.
8. Kadioglu A, Weiser JN, Paton JC, Andrew PW (2008) The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 6: 288-301. (Pubitemid 351404773)
9. Simell B, Auranen K, Kayhty H, Goldblatt D, Dagan R, et al. (2012) The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines 11: 841-855.
10. Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot R, et al. (2004) Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363: 1871-1872. (Pubitemid 38748644)
11. Costerton JW (1999) Introduction to biofilm. Int J Antimicrob Agents 11: 217-221; discussion 237-219.
12. Thomas JG, Litton I, Rinde H (2006) Economic impact of biofilms on treatment costs. Biofilms, Infection and Antimicrobial Therapy, eds Pace JL, Rupp ME, & Finch RG (CRC Press. Taylor and Francis, Boca Raton, FL), : 21-37.
13. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, et al. (2006) Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. Jama 296: 202-211. (Pubitemid 44050374)
14. Sanchez CJ, Shivshankar P, Stol K, Trakhtenbroit S, Sullam PM, et al. (2010) The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. PLoS Pathog 6: e1001044.
15. Weimer KE, Armbruster CE, Juneau RA, Hong W, Pang B, et al. (2010) Coinfection with Haemophilus influenzae promotes pneumococcal biofilm formation during experimental otitis media and impedes the progression of pneumococcal disease. J Infect Dis 202: 1068-1075.
16. Ash SY, Sheffield JV (2013) Pneumococcus. Med Clin North Am 97: 647-666, x-xi.
17. Pichichero ME (2013) Otitis media. Pediatr Clin North Am 60: 391-407.
18. Shak JR, Vidal JE, Klugman KP (2013) Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol 21: 129-135.
19. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322. (Pubitemid 29289651)
20. Parsek MR, Singh PK (2003) Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57: 677-701. (Pubitemid 37392958)
21. Moscoso M, Garcia E, Lopez R (2009) Pneumococcal biofilms. Int Microbiol 12: 77-85.
22. Marcinkiewicz J, Strus M, Pasich E (2013) Antibiotic resistance: a "dark side" of biofilm associated chronic infections. Pol Arch Med Wewn 123: 309-313.
23. Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, et al. (2008) Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 16: 23-29.
24. Imamura Y, Chandra J, Mukherjee PK, Lattif AA, Szczotka-Flynn LB, et al. (2008) Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother 52: 171-182.
25. Donlan RM (2001) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33: 1387-1392.
26. Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193. (Pubitemid 34303762)
27. Ramage G, Martinez JP, Lopez-Ribot JL (2006) Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 6: 979-986. (Pubitemid 44568854)
28. Costerton JW, DeMeo P (2011) Discussion. The role of biofilms: are we hitting the right target? Plast Reconstr Surg 127 Suppl 1: 36S-37S.
29. Wolcott R, Dowd S (2011) The role of biofilms: are we hitting the right target? Plast Reconstr Surg 127 Suppl 1: 28S-35S.
30. Wolcott RD, Rhoads DD, Bennett ME, Wolcott BM, Gogokhia L, et al. (2010) Chronic wounds and the medical biofilm paradigm. J Wound Care 19: 45-46, 48-50, 52-43.
31. Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, et al. (2005) Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 56: 331-336. (Pubitemid 41158521)
32. Aaron SD, Ferris W, Ramotar K, Vandemheen K, Chan F, et al. (2002) Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J Clin Microbiol 40: 4172-4179. (Pubitemid 35285808)
33. Ceri H, Olson ME, Stremick C, Read RR, Morck D, et al. (1999) The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37: 1771-1776. (Pubitemid 29235221)
34. Song JH, Dagan R, Klugman KP, Fritzell B (2012) The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 30: 2728-2737.
35. Song JH (2013) Advances in pneumococcal antibiotic resistance. Expert Rev Respir Med 7: 491-498.
36. Henriques-Normark B, Tuomanen EI (2013) The pneumococcus: epidemiology, microbiology, and pathogenesis. Cold Spring Harb Perspect Med 3.
37. Garcia-Castillo M, Morosini MI, Valverde A, Almaraz F, Baquero F, et al. (2007) Differences in biofilm development and antibiotic susceptibility among Streptococcus pneumoniae isolates from cystic fibrosis samples and blood cultures. J Antimicrob Chemother 59: 301-304. (Pubitemid 47072071)
38. del Prado G, Ruiz V, Naves P, Rodriguez-Cerrato V, Soriano F, et al. (2010) Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-l-cysteine, amoxicillin, erythromycin, and levofloxacin. Diagn Microbiol Infect Dis 67: 311-318.
39. Sanchez CJ, Kumar N, Lizcano A, Shivshankar P, Dunning Hotopp JC, et al. (2011) Streptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production. PLoS One 6: e28738.
40. Marks LR, Parameswaran GI, Hakansson AP (2012) Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo. Infect Immun 80: 2744-2760.
41. Quave CL, Estevez-Carmona M, Compadre CM, Hobby G, Hendrickson H, et al. (2012) Ellagic acid derivatives from Rubus ulmifolius inhibit Staphylococcus aureus biofilm formation and improve response to antibiotics. PLoS One 7: e28737.
42. Quave CL, Plano LR, Pantuso T, Bennett BC (2008) Effects of extracts from Italian medicinal plants on planktonic growth, biofilm formation and adherence of methicillin-resistant Staphylococcus aureus. J Ethnopharmacol 118: 418-428.
43. David MZ, Daum RS (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23: 616-687.
44. Lanie JA, Ng WL, Kazmierczak KM, Andrzejewski TM, Davidsen TM, et al. (2007) Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6. J Bacteriol 189: 38-51. (Pubitemid 46036220)
45. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, et al. (2001) Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293: 498-506. (Pubitemid 32679078)
46. Avery OT, Macleod CM, McCarty M (1944) Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types : Induction of Transformation by a Desoxyribonucleic Acid Fraction Isolated from Pneumococcus Type Iii. J Exp Med 79: 137-158.
47. Vidal JE, Ludewick HP, Kunkel RM, Zahner D, Klugman KP (2011) The LuxS-dependent quorum-sensing system regulates early biofilm formation by Streptococcus pneumoniae strain D39. Infect Immun 79: 4050-4060.
48. Wolter N, Smith AM, Farrell DJ, Schaffner W, Moore M, et al. (2005) Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus. Antimicrob Agents Chemother 49: 3554-3557. (Pubitemid 41060618)
49. Dong W, Chochua S, McGee L, Jackson D, Klugman KP, et al. (2014) Mutations within the rplD gene of linezolid nonsusceptible Streptococcus pneumoniae strains isolated in the USA. Antimicrob Agents Chemother 58: 2459-2462.
50. Nieto C, Espinosa M (2003) Construction of the mobilizable plasmid pMV158GFP, a derivative of pMV158 that carries the gene encoding the green fluorescent protein. Plasmid 49: 281-285. (Pubitemid 36561418)
51. Vidal JE, Howery KE, Ludewick HP, Nava P, Klugman KP (2013) Quorum-sensing systems LuxS/autoinducer 2 and Com regulate Streptococcus pneumoniae biofilms in a bioreactor with living cultures of human respiratory cells. Infect Immun 81: 1341-1353.
52. Shak JR, Ludewick HP, Howery KE, Sakai F, Yi H, et al. (2013) Novel Role for the Streptococcus pneumoniae Toxin Pneumolysin in the Assembly of Biofilms. MBio 4: e00655-00613.
53. CLSI (2009) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard - eighth edition. M07 - A8. Wayne, PA, USA : Clinical and Laboratory Standards Institute. Vol. 29 No.2.
54. Carvalho Mda G, Tondella ML, McCaustland K, Weidlich L, McGee L, et al. (2007) Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 45: 2460-2466. (Pubitemid 47295474)
55. Domenech M, Garcia E, Moscoso M (2011) In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases. Antimicrob Agents Chemother 55: 4144-4148.
56. Yadav MK, Chae SW, Song JJ (2012) Effect of 5-azacytidine on in vitro biofilm formation of Streptococcus pneumoniae. Microb Pathog 53: 219-226.
57. Trappetti C, Kadioglu A, Carter M, Hayre J, Iannelli F, et al. (2009) Sialic acid: a preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host. J Infect Dis 199: 1497-1505.
58. Zampini IC, Villena J, Salva S, Herrera M, Isla MI, et al. (2012) Potentiality of standardized extract and isolated flavonoids from Zuccagnia punctata for the treatment of respiratory infections by Streptococcus pneumoniae: in vitro and in vivo studies. J Ethnopharmacol 140: 287-292.
59. Elaissi A, Rouis Z, Salem NA, Mabrouk S, ben Salem Y, et al. (2012) Chemical composition of 8 eucalyptus species' essential oils and the evaluation of their antibacterial, antifungal and antiviral activities. BMC Complement Altern Med 12: 81.
60. Shiu WK, Malkinson JP, Rahman MM, Curry J, Stapleton P, et al. (2013) A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus. Int J Antimicrob Agents.
61. Baselski V, Klutts JS, Baselski V, Klutts JS (2013) Quantitative cultures of bronchoscopically obtained specimens should be performed for optimal management of ventilator-associated pneumonia. J Clin Microbiol 51: 740-744.